AstraZeneca · 2 weeks ago
Chief Growth Officer– Clinical Development Health Tech Evinova
AstraZeneca is seeking a Chief Growth Officer for their clinical development technology portfolio to drive sustainable growth across enterprise customers in biopharma and healthcare. The role involves leading a high-performance commercial organization and collaborating with various teams to translate customer challenges into impactful solutions.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Design and drive a scalable go-to-market that delivers focused customer engagement and consistent overachievement against bookings, ARR, retention, and expansion targets
Establish CRM subject area, forecast accuracy, pipeline hygiene, and dashboards that surface leading indicators; run weekly pipeline and deal reviews to ensure pipeline health and momentum
Architect an end-to-end growth operating model
Hire, onboard, and develop a high-performance team; elevate processes and tooling across Sales, Revenue Operations, Customer Operations, and Marketing
Implement governance, forecasting cadence, and performance management to achieve predictable success
Lead an Enterprise Strategy Partner model that proactively uncovers high-value opportunities aligned to customer needs and wins new business
Orchestrate strategic account planning, executive engagement, and value-based selling; partner with SMEs to expand within existing accounts
Enable the team to win new study-by-study logos and expand existing relationships using patient engagement clinical trial solutions, including eCOA, digital endpoints, and AI solutions
Guide pursuit strategy, deal shaping, and executive sponsorship
Own bookings, ARR, gross and net retention, and expansion outcomes
Establish deal governance, discount guardrails, and executive approval paths for strategic opportunities; manage performance against targets with precision
Partner with Marketing and Commercial Operations to deliver compelling collateral, return on investment and value calculators, competitive positioning, and objection handling guides
Ensure rigorous enablement on product, compliance, and procurement processes
Bring the voice of the customer to Product and Delivery to influence roadmap, scalability, and deployment readiness
Align with Marketing on ABM, events, and integrated campaigns to build qualified pipeline
Ensure compliant commercial practices for healthcare data and clinical solutions across HIPAA, GDPR, GxP, and 21 CFR Part 11
Maintain audit-ready deal documentation and promote a culture of risk awareness
Qualification
Required
Develop and drive sales strategies which deliver focused customer engagements enabling you and your team to meet and exceed sales targets with scalability and predictable growth
Ensure CRM rigor, forecast accuracy, pipeline hygiene, and dashboards for leading indicators
Provide reports to leadership teams and run weekly pipeline and deal reviews which demonstrate levels of performance and pipeline adaptability
Expand an end‑to‑end growth operating model, hire a high-performance sales team, improve processes, and tooling across Sales, Revenue Operations, Customer Operations, and Marketing
Drive key growth performance metrics, governance, forecasting cadence, and performance management with predictability of success
Lead an Enterprise Strategy Partner consulting model which proactively identifies high value opportunities meeting specific customer challenges and wins new business
Continue to partner cross functionally with SME consulting teams to expand further growth opportunities in each customer to meet sales targets
Drive strategic account planning, executive engagement, and value based selling
Support the sales team to identify new study-by-study logos which leverage patient engagement clinical trial study solutions (including eCOA, digital endpoints and AI solutions) and win new business and/or expand current customer base
Own bookings, ARR, gross and net retention, and expansion targets; manage performance against sales targets
Establish deal governance, discount guardrails, and executive approvals for strategic opportunities
Partner with marketing and commercial operations to develop sales collateral, return on investment/value calculators, competitive positioning, and objection handling
Ensure rigorous enablement on product, compliance, and procurement processes
Bring voice of customer to Product and Delivery; influence roadmap and deployment readiness
Align with Marketing on ABM, events, and integrated campaigns to drive qualified pipeline
Ensure compliant commercial practices for healthcare data and clinical solutions (HIPAA, GDPR, GxP, 21 CFR Part 11) and maintain audit-ready deal documentation
Preferred
Proven success scaling B2B SaaS or platform businesses in life sciences, clinical development, or health tech, including enterprise-wide deployments
Deep understanding of clinical trial operations, including digital health technologies such as eCOA, digital endpoints, eConsent, and AI-driven patient engagement
Established executive relationships across biopharma, CROs, and health systems; experience negotiating complex MSAs, data protection, and quality agreements
Track record implementing value-based selling and executive storytelling tied to measurable outcomes and value
Proficiency in pricing and packaging strategy, revenue forecasting models, and pipeline analytics, proficiency in CRM and sales automation tools
Experience leading high-growth, globally distributed teams with a mentoring attitude and a culture of accountability
Strong command of regulated environments and privacy/security standards; adept at balancing speed with compliance
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Recent News
2026-01-09
2026-01-09
News Powered by Cision
2026-01-08
Company data provided by crunchbase